Our Missions

To generate world-class scientific evidence and translate it into action that eliminates schistosomiasis and neglected tropical diseases across sub-Saharan Africa — while training the next generation of African scientists to lead this fight.

Everything we do — from field surveillance and laboratory science to policy support and community engagement — is measured against a single question: does it move us closer to elimination?

Evidence

Rigorous science, produced on African soil, published to international standards.

Action

Research translated into national programmes that reach real communities.

Legacy

African scientists trained to carry the mission forward for decades to come.

Four priorities shape our next five years — aligned with the WHO NTD Roadmap 2021–2030 and calibrated to the realities of sub-Saharan Africa.

P/01

Accelerate Elimination

Scale precision mapping and mass drug administration to reduce schistosomiasis prevalence below WHO elimination thresholds in endemic Cameroonian districts.

  • Precision MDA targeting
  • Integrated NTD campaigns
  • Post-treatment surveillance
P/02

Strengthen Surveillance

Deploy next-generation diagnostics and geospatial platforms to detect emerging transmission hotspots, drug resistance, and parasite hybridisation earlier.

  • Molecular diagnostics
  • GIS risk modelling
  • Resistance monitoring
P/03

Build African Capacity

Train a new generation of African parasitologists, epidemiologists and public-health scientists through structured MSc, PhD and post-doctoral programmes.

  • Graduate supervision
  • Regional short courses
  • Laboratory fellowships
P/04

Drive Scientific Innovation

Advance functional genomics, ethnopharmacology and integrated One-Health approaches to open new avenues for control, treatment and prevention.

  • Functional genomics
  • Traditional medicine screening
  • One-Health integration

Our work only matters if it reaches the people and institutions that carry it forward. Four groups sit at the centre of everything we do.

  1. 01

    Endemic Communities

    Rural populations in schistosomiasis and STH-endemic districts — school-age children, women, and farming households living along the rivers, lakes and irrigation systems where transmission occurs.

  2. 02

    National Health Authorities

    Cameroon's Ministries of Public Health, Basic and Secondary Education — and their sub-Saharan counterparts — who rely on our evidence to design, target and evaluate national control programmes.

  3. 03

    Global Health Partners

    WHO, funders, and international research consortia advancing the NTD Roadmap 2021–2030 — from Wellcome Trust and LSTM to COUNTDOWN and China–Africa CDC collaborations.

  4. 04

    Next-Generation Scientists

    African MSc, PhD and post-doctoral researchers who train at CSP and return to strengthen parasitology, epidemiology and public health capacity across the continent.

Our field operations span every major schistosomiasis transmission zone in Cameroon, from the Barombi crater lakes in the South-West to the Sahelian corridors of the Far North — with active research collaborations across four continents.

National footprint — Cameroon

9 regions, 30+ sentinel sites

  • CentreYaoundé — headquarters, laboratories, molluscarium
  • LittoralDouala, Loum, Edea, Njombe Penja, Melong
  • South-WestBuea, Tiko, Muyuka, Kumba, Kribi — Barombi crater lakes
  • WestKékem, Foumbot, Makenene
  • North-WestKumbo East, Ndu, Ako
  • EastBertoua, Ndebele, Kette, Doume
  • NorthSahelian transmission zones
  • Far NorthMaroua — high-prevalence corridors
  • SouthCoastal foci monitoring
International collaborations

Four continents, active partnerships

  • United KingdomLSTM, Wellcome Trust — schistosomiasis research
  • FranceSHIS-CAM — hybrid schistosome research
  • BelgiumGhent, Antwerp — parasitology collaboration
  • DenmarkCopenhagen — long-term academic partnership
  • SwitzerlandGeneva, Basel — spatial epidemiology
  • ItalyRome — drug efficacy studies
  • ChinaChina–Africa CDC collaboration (since 2020)
  • LiberiaMinistry of Health & Social Welfare — COUNTDOWN
  • GhanaCOUNTDOWN consortium partner
  • NigeriaCOUNTDOWN consortium partner
  • United StatesFHI 360 — programme implementation
  • South KoreaGood Neighbours — community programmes
30+ Sentinel sites (Cameroon)
12 Partner countries
4 Continents engaged

Our mission plugs into three levels of the international health agenda — global strategy, national programmes, and international research consortia — each with a clear operational role for CSP.

  1. 01 Global

    WHO NTD Roadmap 2021 — 2030

    WHO's flagship strategy for ending the neglect of tropical diseases. Schistosomiasis is prioritised for elimination as a public health problem.

    CSP role
    • WHO Collaborating Center since 2012
    • National reference on schistosomiasis & STH
    • Field evidence for elimination targets
  2. 02 National

    Cameroon National NTD Programme

    PNLSHI — the national control programme run by the Ministry of Public Health with a multi-ministerial MOU across health and education.

    CSP role
    • Scientific arm supporting PNLSHI
    • National disease mapping since 2012
    • School-based MDA support since 2015
    • Partnership with MINSANTE, MINEDUB & MINESEC
  3. 03 Consortium

    International Research Networks

    Long-standing memberships in the international consortia driving schistosomiasis science — where African evidence meets global research capacity.

    CSP role
    • COUNTDOWN consortium — implementation research
    • China–Africa CDC collaboration since 2020
    • SHIS-CAM — hybrid schistosome research (France & UK)
    • Wellcome Trust, LSTM, and other partners

Every activity we run is designed to move along a single chain — from the resources we mobilise to the elimination we aim for.

01 Inputs

What we mobilise

  • Research funding & grants
  • Nine specialised laboratories
  • Scientists, students, technical staff
  • National & international partnerships
02 Activities

What we do

  • Field surveillance & mapping
  • Laboratory analysis & diagnostics
  • MDA campaign support
  • Graduate training & supervision
03 Outputs

What we produce

  • Peer-reviewed publications
  • National risk maps & datasets
  • Trained MSc & PhD scientists
  • Evidence for policy makers
04 Outcomes

What changes

  • Better-targeted MDA campaigns
  • Falling disease prevalence
  • Stronger national health workforce
  • Improved surveillance systems
05 Impact

Long-term change

  • Elimination of schistosomiasis as a public health problem
  • African-led NTD science
  • Sustainable, community-owned control

Three programmes that show how our mission translates on the ground — from national mapping campaigns to hybrid parasite surveillance — each running today, with measurable outputs.

2026 → International research

SHIS-CAM & Hybrid Schistosome Surveillance

Cameroon-led research investigating hybrid schistosome species circulating in Cameroonian river basins, in partnership with French and UK institutions.

PartnersFrance · UK · LSTM
FocusSpecies hybridisation
ImpactGlobal surveillance evidence
2015 → Disease management

National School-Based MDA Programme

Support to Cameroon's national mass drug administration programme — anchored in the MOU between MINSANTE and MINEDUB, delivered through school health teams.

Lead partnerMINSANTE & MINEDUB
DeliverySchool health teams
PopulationSchool-age children
2012 → Research & surveillance

National Disease Mapping & Surveillance

Baseline mapping of schistosomiasis and STH distribution across Cameroon at 1 km² resolution, combining field surveys, snail tracking and satellite imagery.

MethodField + GIS + satellite
Resolution1 km² risk grid
UseNational MDA targeting